+44 (0) 20 7549 9987 | USA callers: 00-1-718-682-4567

Contact Us Now

“The global automation in biopharma market is estimated to reach USD 1.23 billion by 2025” says new Visiongain report

22 May 2020
Pharma

Visiongain has launched a new report Automation in Biopharma Industry 2020-2030: Forecasts by Application (Clinical Stage and Drug Discovery Stage) and by Technologies (Automation Technology (DCS, SCADA, PLC, MES, HMI, APC, ERP, LIMS, CRM, CAPA) and Digital Technology (IoT, AI, Digital Twin, AR & VR, Predictive Analytics, Cloud Computing). Plus, Leading Companies Analysis.

The automation in biopharma market is projected to grow at a CAGR of 4.3% in the first half of the forecast period. In 2019, the automation market in biopharmaceutical industry in clinical stage accounted for 62.1% of the automation in biopharmaceutical market. Visiongain estimated that ERP automation in biopharma will be the driver for market growth in the first half of the forecast period.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

The 142-page Visiongain report provides clear detailed insight into the automation in biopharma market. Discover the key trends and development in the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Automation in biopharma market forecasts from 2020-2030

• This report assesses the application of automation in the biopharma market and gives revenue to 2030

• Provides qualitative analysis and forecast of the submarket by technology for the period 2020-2030:

• Automation Technology
• DCS
• SCADA
• PLC
• MES
• HMI
• APC
• ERP
• LIMS
• CRM
• CAPA

• Digitization Technology
• IoT
• AI
• Digital Twin
• AR & VR
• Predictive Analytics
• Cloud Computing

• Profiles leading companies that will be important in the development of the automation in biopharma market. For each company, developments and outlooks are discussed and companies covered in this chapter include:
• PerkinElmer
• Thermo Fisher Scientific
• Sartorius
• Siemens
• Rockwell
• Zenith (Cognizant)
• RheoSense, Inc.
• Werum
• Emerson
• TetraScience

• Provides qualitative analysis of trends and developments that will affect the automation in biopharma market, from the perspective of biopharmaceutical companies, during the period 2020 to 2030.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Stem Cell Technologies and Applications Market Report 2022-2032

The global stem cell technologies and applications market was valued at US$9,247 million in 2021 and is projected to grow at a CAGR of 8.9% during the forecast period 2022-2032.

01 December 2022

Read

Visiongain Publishes Biosimilars and Follow-On Biologics Market Report 2023-2033

The biosimilars and follow-on biologics market is valued at US$19,668.3 million in 2022 and is projected to grow at a CAGR of 31.14% during the forecast period 2023-2033.

01 December 2022

Read

Visiongain Publishes Medical Imaging Market Report 2022-2032

The Medical Imaging market was valued at US$38.6 billion in 2021 and is projected to grow at a CAGR of 5.46% during the forecast period 2022-2032.

30 November 2022

Read

Visiongain Publishes Antibody Drug Conjugates Market Report 2022-2032

The global antibody drug conjugates market was valued at US$3,668 million in 2021 and is projected to grow at a CAGR of 15.1% during the forecast period 2022-2032.

28 November 2022

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever